| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C0001551> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C0026384> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C0034862> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C0036634> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C0039115> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C0042212> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C0042213> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C0376613> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C0872152> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C2349090> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C2936379> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C3661475> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C4277607> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C5200696> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C5200697> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/32993453_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Principal Consultant, Scientific Strategy, Product Development, Manufacturing, Outsourcing and Emerging Technologies, Gaithersburg, MD, USA.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Rele_Shyam>
?:doi	<https://research.tib.eu/covid-19/entity/10.1080/21645515.2020.1822136>
?:doi	10.1080/21645515.2020.1822136
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Human vaccines & immunotherapeutics
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32993453>
?:pmid	<https://research.tib.eu/covid-19/entity/32993453>
?:pmid	32993453
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32993453>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32993453>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all